Overview

Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. Azithromycin, an antibiotic, may be beneficial at reducing the symptoms and severity of the disease. This study will analyze previously collected study data to evaluate the anti-inflammatory properties of azithromycin and determine how azithromycin affects the frequency and severity of COPD exacerbations.
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Azithromycin